The cell's recycling line fails stage by stage across fifty years — and it fails in a different cell, under a different load, in each phase of the disease. Click any lane or marker to read what breaks there.
Select a pipeline stage on the left, or a diamond marker below the lanes, to see the molecules involved, what fails there, and when it becomes load-bearing.
Macroautophagy is a directional pipeline — formation precedes closure precedes fusion precedes degradation — so a lesion at any stage halts the whole line. And it is bracketed by acidification: nothing upstream counts unless the autolysosome can finally acidify, because un-acidified cargo is cargo undegraded.
Lysosomal acidification is where the corpus locates the disease's narrowest point. The vacuolar ATPase holds the autolysosome near pH 4.5; when it fails, cathepsin activity collapses and every upstream step is voided. Eight largely independent routes — genetic, metabolic, chemical, inflammatory and infectious — converge on this one pump.
A multi-subunit machine: a membrane-embedded V0 sector and a cytosolic V1 sector, requiring continuous ATP hydrolysis, lipid-raft scaffolding for assembly, and regulated reversible dissociation. The V0a1 subunit is the named target of the amyloid route. "When lysosomal pH rises above the critical threshold, cathepsin activity collapses, autophagic cargo accumulates, and the degradative system catastrophically fails."
Autophagic failure is not a private lesion. It shares machinery with mitophagy, it manufactures the amyloid it cannot clear, it disarms the microglion, and it hands its undigested residue to the extracellular tier. Each card names the specific coupling and its direction.
The corpus grades its own strongest thesis, and its internal audits attack it hard. Green = established; amber = bridging inference; red = contested or explicitly flagged as over-claimed.